| Prev Close | 210.14 |
| Open | 208.81 |
| Day Low/High | 208.81 / 214.48 |
| 52 Wk Low/High | 150.37 / 236.62 |
| Volume | 1.90M |
Constellation Brands, Inc. Class A (STZ)
212.16
2.02
0.96
NYSE
| Exchange | NYSE |
| Shares Outstanding | 190.21B |
| Market Cap | 39.97B |
| Div & Yield | N.A. (N.A) |
Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
I Own Alphria Stock and the Big Q3 Loss Was Not a Surprise
The company has spent a lot of time and money trying to meet the supply needs of the recreational cannabis market.
2 Huge Earnings Reports I'm Watching This Week
A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.
Here's How to Trade Constellation Brands Stock
Oh, by the way, Constellation, for those who've forgotten, holds a 38% stake in Canopy Growth.
Constellation Brands Stock Can Still Run Despite Downgrade
There is certainly too much to ignore about STZ for the majority of analysts.
Jim Cramer: Betting That the Next Pieces of News Will Be Very Stock Heartening
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
Constellation Brands Focuses on Beer, Tesla Deliveries Underwhelm
What I do know is that TSLA now faces a tumultuous uphill battle in order to meet its full year guidance.
Investing in 5G, the Next Industrial Revolution; What I Think About Apple Stock
I am upping my Apple price target.
2 Important Earnings Reports I'm Watching This Week
What to look for when Dave & Buster's and Constellation Brands report results.
About Those CBD-Infused Beverages
I've noted a few names from the comments that may be involved in the CBD-infused beverage market in the form of New Age Beverage Corp. and Constellation Brands . While I'm a big supporter in the potential of CBD and cannabis, I have my reservations ...
Cannabis Enters Its Most Challenging Stage for Investors and Traders
Not to be outcome by a unicorn company, the unicorn sector of the markets, cannabis, is unleashing a blitzkrieg of news this morning. On the acquisition side, Cresco Labs is buying Origin House (CannaRoyalty) this morning for a small premium. It app...
7 Indirect Stock Plays on the Cannabis Sector
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
Tilray Stock Lights Up as Partnerships Obscure Profitability Problem
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Chart of the Day: Vetting the Value of Cannabis Companies
Assessing Aurora and its peers, strictly on the numbers.
Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot
In this day and age, companies must be 'disruptors' or get left in the dust.
Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
Melius Research Launches Cannabis Industry Coverage
In its first report on cannabis companies, Melius says prices are high.
Jim Cramer: My Best Stock Picks for Cannabis and China
And why I won't recommend any other stocks in these markets, right now.
A Creative Way to Play Cannabis Stock Canopy Growth
If you are looking to invest in the fast-growing pot sector, this Canadian cannabis startup has been in early on the action.
Now Isn't the Time to Gauge Marijuana Stocks
Right now they are speculative growth stocks through and through.
How Are My Ideas Working Out? January Trade Review (Part 1)
Eight of these 11 trade ideas are in the green, with a few big winners.
SLANG Is the Cannabis IPO to Watch This Week
While consolidation may be key to the cannabis market in 2019, this IPO is worthy of a deeper dive.
Excuse Me, Would You Like Some Cannabis With Your Coffee?
CBD could make coffee an around the clock craze.
Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
Chart of the Day, Part 1: Canopy Growth Could Be Key to Constellation Long Term
Analysts have noted that the weed leader's momentum is set to burn higher moving forward.
How to Trade Constellation Brands Now Using Options
I'm strategizing a risk reversal here using a put sale to fund a long-side play.
